These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3769241)

  • 21. Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome.
    Kay RA; Hay EM; Holt PJ; Bernstein RM; Ollier WE
    Br J Rheumatol; 1994 Feb; 33(2):193-4. PubMed ID: 8162491
    [No Abstract]   [Full Text] [Related]  

  • 22. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
    Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
    Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome.
    Reveille JD
    Curr Opin Rheumatol; 1992 Oct; 4(5):644-56. PubMed ID: 1419498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA associations in a family with autoimmune phenomena.
    Hübscher O; Fernandez L; Moreno MJ
    Clin Exp Rheumatol; 1999; 17(2):262. PubMed ID: 10342060
    [No Abstract]   [Full Text] [Related]  

  • 25. Linkage studies of HLA and primary Sjögren's syndrome in multicase families.
    Foster H; Stephenson A; Walker D; Cavanagh G; Kelly C; Griffiths I
    Arthritis Rheum; 1993 Apr; 36(4):473-84. PubMed ID: 8457223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial Risk of Sjögren's Syndrome and Co-aggregation of Autoimmune Diseases in Affected Families: A Nationwide Population Study.
    Kuo CF; Grainge MJ; Valdes AM; See LC; Luo SF; Yu KH; Zhang W; Doherty M
    Arthritis Rheumatol; 2015 Jul; 67(7):1904-12. PubMed ID: 25940005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA antigens in anti-Ro(SS-A)-positive patients with recurrent annular erythema.
    Miyagawa S; Dohi K; Shima H; Shirai T
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):185-8. PubMed ID: 8432914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial CRST syndrome with sicca complex.
    Frayha RA; Tabbara KF; Geha RS
    J Rheumatol; 1977; 4(1):53-8. PubMed ID: 886553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathogenesis of Sjögren's syndrome.
    Moutsopoulos HM
    Isr J Med Sci; 1988 Dec; 24(12):737-9. PubMed ID: 3066783
    [No Abstract]   [Full Text] [Related]  

  • 30. The genetics of primary Sjögren's syndrome.
    Sawalha AH; Potts R; Schmid WR; Scofield RH; Harley JB
    Curr Rheumatol Rep; 2003 Aug; 5(4):324-32. PubMed ID: 14531961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Connective tissue diseases: Sjögren syndrome genetics vary according to ancestry.
    Reksten TR; Jonsson R
    Nat Rev Rheumatol; 2017 Apr; 13(4):202-203. PubMed ID: 28275262
    [No Abstract]   [Full Text] [Related]  

  • 32. HLA system and autoantibodies in primary Sjögren's syndrome.
    Panchovska M; Sheytanov Y; Martinova F
    Bratisl Lek Listy; 2002; 103(1):41-2. PubMed ID: 12061088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic markers in Sjögren's syndrome: the question of its genetic heterogeneity.
    Papiha SS; Pal B; Griffiths ID; Roberts DF; Dick WC
    Br J Rheumatol; 1988 Aug; 27(4):265-74. PubMed ID: 3165682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
    Mattey DL; González-Gay MA; Hajeer AH; Dababneh A; Thomson W; García-Porrúa C; Ollier WE
    J Rheumatol; 2000 Nov; 27(11):2611-6. PubMed ID: 11093441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunopathogenesis of Sjogren's syndrome: "facts and fancy".
    Moutsopoulos HM; Manoussakis MN
    Autoimmunity; 1989; 5(1-2):17-24. PubMed ID: 2519015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between HLA and Sjögren's syndrome in Japanese patients.
    Moriuchi J; Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Sato K; Tsuji K; Arimori S
    Arthritis Rheum; 1986 Dec; 29(12):1518-21. PubMed ID: 3801073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases.
    Op De Beéck K; Maes L; Van den Bergh K; Derua R; Waelkens E; Van Steen K; Vermeersch P; Westhovens R; De Vlam K; Verschueren P; Hooijkaas H; Blockmans D; Bossuyt X
    Arthritis Rheum; 2012 Jan; 64(1):213-21. PubMed ID: 21905010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aberrant expression of HLA-DR antigens on acinar and ductal epithelial cells of salivary glands in Sjögren's syndrome].
    Nakamura S; Hiroki A; Shinohara M
    Nihon Rinsho; 1995 Oct; 53(10):2407-11. PubMed ID: 8531346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of DR3 with susceptibility to and severity of primary Sjögren's syndrome in a family study.
    Foster H; Walker D; Charles P; Kelly C; Cavanagh G; Griffiths I
    Br J Rheumatol; 1992 May; 31(5):309-14. PubMed ID: 1581772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.